untitled
<OAI-PMH schemaLocation=http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd>
<responseDate>2018-01-17T12:06:07Z</responseDate>
<request identifier=oai:HAL:inserm-01567222v1 verb=GetRecord metadataPrefix=oai_dc>http://api.archives-ouvertes.fr/oai/hal/</request>
<GetRecord>
<record>
<header>
<identifier>oai:HAL:inserm-01567222v1</identifier>
<datestamp>2017-12-21</datestamp>
<setSpec>type:ART</setSpec>
<setSpec>subject:sdv</setSpec>
<setSpec>collection:INSERM</setSpec>
<setSpec>collection:UNIV-AG</setSpec>
<setSpec>collection:SANTE_PUB_INSERM</setSpec>
</header>
<metadata><dc>
<publisher>HAL CCSD</publisher>
<title lang=en>End stage renal disease in French Guiana (data from R.E.I.N registry): South American or French?</title>
<creator>Rochemont, Dévi-Rita</creator>
<creator>Meddeb, Mohamed</creator>
<creator>Roura, Raoul</creator>
<creator>Couchoud, Cécile</creator>
<creator>Nacher, Mathieu</creator>
<creator>Basurko, Célia</creator>
<contributor>Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane) ; Université des Antilles et de la Guyane (UAG) - Institut National de la Santé et de la Recherche Médicale (INSERM) - CHU de Pointe-à-Pitre - Centre Hospitalier de Cayenne Andrée Rosemon - CHU de Fort de France</contributor>
<contributor>KAPA santé [Cayenne, Guyane Française] ; Clinique Véronique [Cayenne, Guyane Française]</contributor>
<contributor>Association Traitement de l’Insuffisance Rénale [Cayenne, Guyane Française] (ATIRG) ; Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]</contributor>
<contributor>Registre REIN [Saint-Denis La Plaine, France] ; Biomedecine Agency [Saint-Denis La Plaine, France]</contributor>
<contributor>The REIN registry is funded by “Agence de la Biomedecine (ABM)”.</contributor>
<description>International audience</description>
<source>ISSN: 1471-2369</source>
<source>BMC Nephrology</source>
<publisher>BioMed Central</publisher>
<identifier>inserm-01567222</identifier>
<identifier>http://www.hal.inserm.fr/inserm-01567222</identifier>
<identifier>http://www.hal.inserm.fr/inserm-01567222/document</identifier>
<identifier>http://www.hal.inserm.fr/inserm-01567222/file/2017%2C%20Rochemont%20-%20End%20stage%20renal%20disease.pdf</identifier>
<source>http://www.hal.inserm.fr/inserm-01567222</source>
<source>BMC Nephrology, BioMed Central, 2017, 18 (1), pp.207. 〈10.1186/s12882-017-0614-6〉</source>
<identifier>DOI : 10.1186/s12882-017-0614-6</identifier>
<relation>info:eu-repo/semantics/altIdentifier/doi/10.1186/s12882-017-0614-6</relation>
<identifier>PUBMED : 28666409</identifier>
<relation>info:eu-repo/semantics/altIdentifier/pmid/28666409</relation>
<identifier>PUBMEDCENTRAL : PMC5493068</identifier>
<language>en</language>
<subject lang=en> Prevalence</subject>
<subject lang=en> End stage renal failure </subject>
<subject lang=en>Co-morbidities</subject>
<subject lang=en> Epidemiology</subject>
<subject lang=en> French Guiana</subject>
<subject lang=en> Incidence</subject>
<subject>[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie</subject>
<type>info:eu-repo/semantics/article</type>
<type>Journal articles</type>
<description lang=en>Background: End-Stage renal disease (ESRD) causes considerable morbidity and mortality, and significantly alterspatients’ quality of life. There are very few published data on this problem in the French Overseas territories. Thedevelopment of a registry on end stage renal disease in French Guiana in 2011 allowed to describe the magnitudeof this problem in the region for the first time.Methods: Using data from the French Renal Epidemiology and Information Network registry (R.E.I.N). Descriptivestatistics on quantitative and qualitative variables in the registry were performed on prevalent cases and incidentcases in 2011, 2012 and 2013.Results: French Guiana has one of the highest ESRD prevalence and incidence in France. The two main causes ofESRD were hypertensive and diabetic nephropathies. The French Guianese population had a different demographicprofile (younger, more women, more migrants) than in mainland France. Most patients had at least one comorbidity,predominantly (95.3%) hypertension. In French Guiana dialysis was initiated in emergency for 71.3% of patients versus33% in France (p < 0.001).Conclusion: These first results give important public health information: i) End stage renal disease has a very highprevalence relative to mainland France ii) Patients have a different demographic profile and enter care late in thecourse of their renal disease. These data are closer to what is observed in the Caribbean or in Latin America than inMainland France.</description>
<date>2017-06-30</date>
</dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
